Leerink, Cantor Fitzgerald and Oppenheimer acted as joint book running managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AQST:
- Aquestive Therapeutics Secures $75M Funding for Anaphylm
- Aquestive Therapeutics announces $75M strategic funding agreement with RTW
- Aquestive Therapeutics Reports Q2 2025 Financial Results
- AQST Earnings this Week: How Will it Perform?
- Aquestive Therapeutics Faces Potential Risks with ‘5050Item’: What Investors Need to Know